GPR161 anticorps (AA 180-260)
Aperçu rapide pour GPR161 anticorps (AA 180-260) (ABIN7228714)
Antigène
Voir toutes GPR161 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 180-260
-
Fonction
- Rabbit Anti-GP161 Polyclonal Antibody
-
Specificité
- The antibody detects endogenous levels of GP161 protein
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from part region of human GP161 protein at AA range: 180-260
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
Date de péremption
- 12 months
-
-
- GPR161 (G Protein-Coupled Receptor 161 (GPR161))
-
Autre désignation
- GP161
-
Sujet
- G-protein coupled receptor 161, G-protein coupled receptor RE2The protein encoded by GPR161 is an orphan G protein-coupled receptor whose ligand is unknown. GPR161 is overexpressed in triple-negative breast cancer, and disruption of this gene slows the proliferation of basal breast cancer cells. Therefore, GPR161 is a potential drug target for triple-negative breast cancer.
-
Poids moléculaire
- 58kD
-
ID gène
- 23432
-
UniProt
- Q8N6U8
-
Pathways
- cAMP Metabolic Process
Antigène
-